Publications
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | First Faculty of Medicine
- Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network2013 | First Faculty of Medicine
- Natural compounds and their anticancer potential2013 | First Faculty of Medicine
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | First Faculty of Medicine, Third Faculty of Medicine
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- Cell-specific modulation of mitochondrial respiration and metabolism by the pro-apoptotic Bcl-2 family members Bax and Bak2023 | First Faculty of Medicine, Faculty of Science
- Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping2023 | First Faculty of Medicine
- Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma2023 | First Faculty of Medicine
- BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis2023 | First Faculty of Medicine
Loading network view...